An “evidence-based” survey of therapeutic options for IgA nephropathy: assessment and criticism
- 30 June 2003
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (6) , 1129-1139
- https://doi.org/10.1016/s0272-6386(03)00344-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologistsThe American Journal of Medicine, 2001
- Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathyAmerican Journal of Kidney Diseases, 2000
- Management of IgA nephropathy: Evidence-based recommendationsKidney International, 1999
- Corticosteroids in IgA nephropathy: a randomised controlled trialThe Lancet, 1999
- A Controlled Trial of Combined Therapy for Newly Diagnosed Severe Childhood IgA NephropathyJournal of the American Society of Nephrology, 1999
- Fish oil therapy for IgA nephropathyJournal of the American Society of Nephrology, 1997
- A Controlled Trial of Fish Oil in IgA NephropathyNew England Journal of Medicine, 1994